可生物降解支架市场
可生物降解支架市场：2026年市场规模约为6.8亿美元，2031年市场规模约为11.6亿美元；预测期复合年增长率为11.28%；当前最大市场为北美；增长最快的市场为亚太地区。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
可生物降解支架市场：2026年市场规模约为6.8亿美元，2031年市场规模约为11.6亿美元；预测期复合年增长率为11.28%；当前最大市场为北美；增长最快的市场为亚太地区。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 11.28% | 机构预测 |
| 市场规模 | 2026 | USD 0.68 billion | 机构预测 |
| 市场规模 | 2031 | USD 1.16 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| application | orthopedics, musculoskeletal, and spine | 2025 | 26.960% |
| end_user | biotechnology and pharmaceutical companies | 2025 | 52.920% |
| material_type | collagen | 2025 | 44.430% |
| product_type | hydrogels | 2025 | 35.780% |
| technology | 3D printing | 2025 | 39.520% |
关键结论
- application 维度中，orthopedics, musculoskeletal, and spine 在 2025 年的公开份额为 26.96%。
- end_user 维度中，biotechnology and pharmaceutical companies 在 2025 年的公开份额为 52.92%。
- material_type 维度中，collagen 在 2025 年的公开份额为 44.43%。
- product_type 维度中，hydrogels 在 2025 年的公开份额为 35.78%。
- technology 维度中，3D printing 在 2025 年的公开份额为 39.52%。
主要参与者
- Medtronic
- Merck KGaA
- Smith+Nephew plc
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Increasing Adoption of Regenerative Medicine and Tissue Engineering | +2.800% | Global, concentrated in North America and Europe | Long term (≥ 4 years) |
| Rising Orthopedic, Spine, Trauma, and Chronic-Wound Burden | +2.300% | Global, with APAC and North America leading procedural volumes | Medium term (2-4 years) |
| 3D Printing and Patient-Specific Scaffold Manufacturing | +2.100% | North America and Europe, with early APAC gains in Japan and South Korea | Medium term (2-4 years) |
| Translation of Scaffold-Based Cell, Drug-Delivery, and Organ-Repair Platforms | +1.400% | North America, Europe, and Japan | Long term (≥ 4 years) |
| GMP Outsourcing and CDMO Capacity Expansion for Clinical-Grade Scaffolds | +0.900% | North America and Europe, with spillover to India and South Korea | Medium term (2-4 years) |
| Hospital Procurement Preference for Temporary, Resorbable Implants | +0.800% | Global, with early gains in GCC and Southeast Asia | Short term (≤ 2 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Long Clinical Validation and Regulatory Classification Cycles | -1.400% | Global, acute in Europe after the MDR transition | Long term (≥ 4 years) |
| High Cost of GMP Manufacturing, Sterility Assurance, and Reimbursement Evidence | -1.100% | Global, most pronounced in emerging-market hospital segments | Medium term (2-4 years) |
| Trade-Offs Between Mechanical Strength, Degradation Rate, and Biocompatibility | -0.700% | Global, with specific effects in load-bearing orthopedic uses | Long term (≥ 4 years) |
| Lot-Release Variability from Biomaterial and Sterilization Sensitivity | -0.500% | Global, with higher exposure in collagen and dECM categories | Medium term (2-4 years) |
报告关注的关键问题
What is the projected value of biodegradable scaffolds by 2031?
The biodegradable scaffold market is forecast to reach USD 1.16 billion by 2031, growing at an 11.28% CAGR from 2026.
Which product category leads revenue?
Hydrogels led product revenue with a 35.78% share in 2025 because they support cell encapsulation, drug delivery, and injectable use.
Which scaffold technology is growing fastest?
Decellularized technology is projected to grow at 12.36% CAGR through 2031, supported by advances in standardized tissue processing.
Which material has the fastest growth outlook?
PCL is projected to expand at 12.89% CAGR through 2031, supported by its processability and 12 to 18 month degradation profile.
Which application is expanding fastest?
Cardiology and vascular applications are expected to grow at 13.59% CAGR through 2031.
Which region has the highest growth rate?
Asia-Pacific is forecast to grow at 14.83% CAGR through 2031, supported by regional regenerative medicine capacity and domestic production.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence